Data Analysis for the Quality, Safety & Oversight of the End Stage Renal Disease (ESRD), Transplant, and Organ Procurement Organization (OPO) Programs
Subject: Data Analysis for the Quality, Safety & Oversight of the End Stage Renal Disease (ESRD), Transplant, and Organ Procurement Organization (OPO) ProgramsSolicitation Number: 260109JNotice Type: SOLICITNAICS: 541720Set-Aside: No Set aside usedNotice Published: 06-10-26Response Due: 06-25-26Agency: Department of Health and Human ServicesOffice: CENTERS FOR MEDICARE AND MEDICAID SERVICESContact: Joshua Czerski This email address is being protected from spambots. You need JavaScript enabled to view it.Office Address: BALTIMORE, MD 21244Place of Performance: Baltimore, MD Related Notices:
Click for official SAM (FBO) notice, additional information, and accompanying attachments
CMS requires the contractor produce detailed data reports on End-Stage Renal Disease (ESRD) dialysis facilities, Transplant Programs, and Organ Procurement Organizations (OPOs) in formats useful to CMS, States, healthcare providers, and the general public. The reports will include summaries of patient and facility characteristics, patient outcomes, facility practice patterns, and comparative State, Network, Regional, and National statistics. These reports serve as the foundation for CMS's oversight of the quality and safety of ESRD, Transplant, and OPO programs. The contractor shall produce and distribute the following reports and analytical products: Facility-specific Dialysis Facility Reports (DFRs) Initial Transplant Program Reports (monthly) Transplant Composite Reports for survey scheduling Organization-specific Organ Procurement Organization (OPO) Reports State-specific and Regional-specific reports State-specific rank-ordered Outcomes Lists, including reversed top-performer versions for public access All reports shall be posted to a secure website and distributed in a timely manner to support CMS surveyors, State Agencies, and other oversight stakeholders. This requirement is non-commercial in nature, as it cannot be readily procured through the commercial marketplace without substantial modification to commercial specifications. AMENDMENT-1: 6/10/2026 - SEE UPDATED PRE-SOLICITATION NOTICE ATTACHMENT - "Pre-Solicitation Notice - Sole Source Synopsis 20260610" AMENDMENT-2: 6/10/2026 - SEE UPDATED PRE-SOLICITATION NOTICE ATTACHMENT - "Pre-Solicitation Notice - Sole Source Synopsis 20260610" to include the following in Response Instructions: "Responses will be used for market research purposes only and will not be considered a request for proposal or an obligation by the Government to issue a solicitation."